Bernard Ravina's most recent trade in Praxis Precision Medicines Inc was a trade of 65,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 22, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines Inc | Bernard Ravina | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Bernard Ravina | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.85 per share. | 12 Feb 2022 | 3,057 | 99,476 | - | 12.8 | 39,282 | Common Stock |
| Praxis Precision Medicines Inc | Bernard Ravina | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 77,000 | 77,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Bernard Ravina | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 22,000 | 102,533 | - | 0 | Common Stock |